Perhaps most concerning, a 25-year ARIC cohort study published in eBioMedicine of over 11,000 adults found that chronic under-hydration was linked to a 39% increased risk of chronic diseases, 1015% higher odds of being biologically older than your actual age, and elevated risk of early death
Semaglutide- and tirzepatide-class medications carry real, documented risks discussed in the safety section above
As peptide drugs become more central to treating chronic and multifactorial diseases, the importance of and reliance on analytical capabilities will only increase
Schedule your consultation today and lets explore whats possible for youright here in Wesley Chapel.
In a landmark 40-week Phase 3 trial with 1,973 patients with type 2 diabetes, Tirzepatide at 5 mg, 10 mg, and 15 mg doses achieved 4-12 pounds greater weight loss than Semaglutide (1 mg)
Molecules 26, 7431